RightAnswer Knowledge Solutions Search Results for 1197-18-8

New Search  |  Search Results (1197-18-8)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • MSDS Documents
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp

All Other Data Sources:

Fisher MSDShelp
LOLI® Listingshelp
REPROTOX® Documentshelp
RTECS® Registryhelp
Shepard's Cataloghelp
MSDSonline®help

ChemID External Links:

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for 1197-18-8:


Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

  1. USES: Tranexamic acid is indicated for the short-term use (2 to 8 days) to reduce or prevent hemorrhage and to reduce the need for replacement therapy during and following tooth extraction in hemophiliac patients.
  1. PHARMACOLOGY: Tranexamic acid is a synthetic amino acid analogue that interferes with the activation of plasminogen to plasmin. This produces an antifibrinolytic effect preventing clot breakdown reducing the risk of bleeding.
  1. EPIDEMIOLOGY: Overdoses are rare. Several cases of unintentional administration of tranexamic acid have been reported.
  1. WITH THERAPEUTIC USE
    1. ADVERSE EFFECTS: COMMON: Nausea, vomiting, and diarrhea are common occurrences with tranexamic acid therapy. INFREQUENT: Adverse effects that may occur less frequently following therapeutic administration of tranexamic acid include thromboembolism, myocardial infarction, renal cortical necrosis, visual disturbances, headaches and giddiness.
  1. WITH POISONING/EXPOSURE
    1. MILD TO MODERATE TOXICITY: Tranexamic overdose data are limited. Nausea, vomiting, orthostatic hypotension may occur in the event of an overdose.
    1. SEVERE TOXICITY: The major adverse events due to tranexamic acid are the potential thromboembolic events, such as myocardial infarctions, deep vein thrombosis, and pulmonary embolism. Severe pain, seizures, myoclonic twitching of facial muscles, ventricular fibrillation, coma, and death have been reported in patients following unintentional intrathecal administration of tranexamic acid.
© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.